China Issues has been saved
Navigating what’s next
How did the US and China life sciences and health care (LSHC) sector perform in the past 18 months with many companies facing headwinds such as lower GDP growth, US-China trade frictions, and the COVID-19 pandemic? These and other new dynamics could influence the future of health in the two countries. Participants will review key industry trends and learn about new opportunities and challenges that are reshaping the US and China LSHC market.
Technology trends: How do they translate in the Chinese market?
February 13, 2020